Michelle Seitz
Michelle Seitz has served as a Director since August 2024. Ms. Seitz is currently the Founder and CEO of MeydenVest Partners, a role she has held since September 2022. Before MeydenVest Partners, Ms. Seitz served at Russell Investments as Chief Executive Officer from September 2017 to October 2022, and as Chairman of the Board from January 2018 to September 2022. Prior to joining Russell Investments, Ms. Seitz held various senior level positions at William Blair from February 1996 to August 2017, most recently serving as the Chief Executive Officer of William Blair Investment Management, Chair and President of William Blair Funds, and as a member of the Board of Directors from June 2001 to August 2017. Ms. Seitz has served as a director of Sana Biotechnology, Inc. (NASDAQ: SANA) since November 2020 and a member of their Audit Committee since December 2020. Ms. Seitz holds a Bachelor of Science degree in Accounting from the Kelley School of Business at Indiana University, and is a Chartered Financial Analyst (CFA).
Ms. Seitz has deep experience in the investment industry, having spent more than three decades in asset management and private wealth, both as a CEO and as an investor. She has driven transformational growth while fostering an award-winning, client-centric culture. Ms. Seitz has been recognized as one of the most influential women in U.S. finance.